Private Investments
Examples of Mosaix's liquidation events include:
ACIST Medical manufactures state-of-the art contrast injection systems used in cardiac catherization and radiology labs for both diagnostic and interventional procedures. ACIST was acquired by the Bracco Group in 2001. (www.acist.com)
American WholeHealth Networks is a leading provider of integrative medicine services that manages one of the most comprehensive networks of Complementary and Alternative Medicine practitioners for health plans. American WholeHealth Networks was acquired by Axia Health Management in 2005 which subsequently merged with Healthways in 2006. (www.healthways.com)
Array BioPharma is a biopharmaceutical company focused on the discovery, development and commercialization of orally active drugs designed to regulate targets in therapeutically important biologic pathways in cancer and inflammatory disease. Array BioPharma had a successful IPO in 2001. (www.arraybiopharma.com)
Public Investments
Noteworthy examples of our negotiated and open market investments in public companies include:
Netsmart Technologies provides comprehensive financial, clinical and management solutions to more than 1,300 organizations including over 30 state systems and is a trusted partner to a variety of health and human services sectors including Behavioral Health, Mental Health, Public Health, Substance Abuse, Methadone, MR/DD and Social Services. Netsmart Technologies was acquired via a public-to-private transaction in 2007. (www.ntst.com)
Omnicell Inc. offers primary automation solutions across various clinical areas of the healthcare facility (e.g.; central pharmacy, nursing units, operating room, cardiac catheterization lab, and patient's bedside) that improve the acquisition, management, dispensing, and administration of medications and medical-surgical supplies. (www.omnicell.com)
Therasense
Inc. develops and manufactures leading edge glucose monitoring systems and test strips for use in both the home and hospital settings. Therasense was acquired by Abbott Laboratories in April 2004.
|
|